Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra

Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
(NASDAQ: MDGL) Delayed: 530.00 +10.91 (2.10%)
Previous Close $519.09    52 Week High $18.24 
Open $520.09    52 Week Low $6.60 
Day High $530.09    P/E N/A 
Day Low $519.00    EPS $0.00 
Volume 33,310